Interferon Induces Expression of the Immune Checkpoint PD-L1 via Bcl3 Upregulation in Ovarian Cancer Cells

被引：0
|
作者：
Zou, Yue [1 ]
Uddin, Mohammad [1 ]
Padmanabhan, Sveta [1 ]
Gaire, Bijaya [1 ]
Vancurova, Ivana [1 ]
机构：
[1] St Johns Univ, Biol Sci, Jamaica, NY 11439 USA
来源：
FASEB JOURNAL | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
792.16
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The immune checkpoint PD-L1 alters choline kinase expression and metabolism in triple negative breast cancer cells
    Pacheco-Torres, Jesus
    Penet, Marie-France
    Wildes, Flonne
    Mironchik, Yelena
    Krishnamachary, Balaji
    Bhujwalla, Zaver M.
    CANCER RESEARCH, 2020, 80 (16)
  • [32] PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
    Dermani, Fatemeh K.
    Samadi, Pouria
    Rahmani, Golebagh
    Kohlan, Alisa K.
    Najafi, Rezvan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) : 1313 - 1325
  • [33] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    MODERN PATHOLOGY, 2019, 32
  • [34] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Iosune Baraibar
    Ignacio Melero
    Mariano Ponz-Sarvise
    Eduardo Castanon
    Drug Safety, 2019, 42 : 281 - 294
  • [35] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
    Sharma, Meenal
    Yang, Qi
    Mcmahon, Loralee
    Miyamoto, Hiroshi
    LABORATORY INVESTIGATION, 2019, 99
  • [36] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
  • [37] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Baraibar, Iosune
    Melero, Ignacio
    Ponz-Sarvise, Mariano
    Castanon, Eduardo
    DRUG SAFETY, 2019, 42 (02) : 281 - 294
  • [38] Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
    Sharma, Meenal
    Yang, Zhiming
    Miyamoto, Hiroshi
    MEDICINE, 2019, 98 (38)
  • [39] Scoparone attenuates PD-L1 expression in human breast cancer cells by MKP-3 upregulation
    Kim, Seung-Woo
    Kim, Chan Woo
    Kim, Hong Seok
    ANIMAL CELLS AND SYSTEMS, 2024, 28 (01) : 55 - 65
  • [40] Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
    Imai, Yushi
    Chiba, Tetsuhiro
    Kondo, Takayuki
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Ao, Junjie
    Kojima, Ryuta
    Kusakabe, Yuko
    Nakamura, Masato
    Saito, Tomoko
    Nakagawa, Ryo
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Tawada, Akinobu
    Matsumura, Tomoaki
    Nakagawa, Tomoo
    Kato, Jun
    Kotani, Ai
    Matsubara, Hisahiro
    Kato, Naoya
    ONCOLOGY LETTERS, 2020, 20 (03) : 2161 - 2168
12345